 |
|
Routine Pulmonary Function Tests During Bleomycin TherapyTests May Be Ineffective and Potentially Misleading
Benjamin M. Lewis, MD;
Ronald Izbicki, DO
JAMA. 1980;243(4):347-351.
Abstract
Forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLco) studies in two patients with proved interstitial fibrosis after low doses of bleomycin were contrasted with these measurements in 21 patients who received bleomycin without toxicity. The FVC decreased significantly (20% or more) in both fibrosis patients and in seven others. In one fibrosis patient and in three others the results could be explained by weakness. The DLco fell in both patients with fibrosis and in 12 others. Correction for decrease in hemoglobin level accounted for the change in one of the toxic patients and seven of the others, but hemoglobin correction made two insignificant changes significant and increased therapy values above control four times. Since these tests have many false-positive results and can be affected by weakness and anemia leading to false-negative results their use is ineffective and may be misleading.
(JAMA 243:347-351, 1980)
Author Affiliations
From the Hutzel Hospital Medical Unit, Wayne State University, Detroit (Dr Lewis) and the Department of Oncology, Harper-Webber Hospital and Wayne State University (Dr Izbicki). Dr Izbicki is now with the Crittendon Hospital, Rochester, Mich.
Footnotes
Reprint requests to Hutzel Hospital, 4707 St Antoine, Detroit, MI 48201 (Dr Lewis).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Bleomycin lung: a case report
Rashid
BMJ Case Reports 2009;2009:bcr1120081175-bcr1120081175.
ABSTRACT
| FULL TEXT
Bleomycin Pulmonary Toxicity Has a Negative Impact on the Outcome of Patients With Hodgkin's Lymphoma
Martin et al.
JCO 2005;23:7614-7620.
ABSTRACT
| FULL TEXT
|
